An NDM-Producing Escherichia coli Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance

BACKGROUND: Cefiderocol and ceftazidime-avibactam plus aztreonam (CZA-ATM) are preferred treatment regimens for New Delhi metallo-β-lactamase (NDM)-producing infections. METHODS: We report the case of a US patient who traveled to India to receive a renal transplant. He subsequently experienced pyelo...

Descripción completa

Detalles Bibliográficos
Autores principales: Simner, Patricia J, Bergman, Yehudit, Conzemius, Rick, Jacobs, Emily, Tekle, Tsigereda, Beisken, Stephan, Tamma, Pranita D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319620/
https://www.ncbi.nlm.nih.gov/pubmed/37416757
http://dx.doi.org/10.1093/ofid/ofad276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319620/
https://www.ncbi.nlm.nih.gov/pubmed/37416757
http://dx.doi.org/10.1093/ofid/ofad276

Ejemplares similares